Startseite>>Signaling Pathways>> Others>> Organ- & System-Specific Toxicity>>(±)-2-propyl-4-Pentenoic Acid

(±)-2-propyl-4-Pentenoic Acid (Synonyms: 2-Allylpentanoic Acid, 4-ene VPA )

Katalog-Nr.GC18596

(±)-2-Propyl-4-pentensÄure (4-en-VPA) ist ein wichtiger toxischer Metabolit von ValproinsÄure.

Products are for research use only. Not for human use. We do not sell to patients.

(±)-2-propyl-4-Pentenoic Acid Chemische Struktur

Cas No.: 1575-72-0

Größe Preis Lagerbestand Menge
10mg
44,00 $
Auf Lager
25mg
162,00 $
Auf Lager
50mg
281,00 $
Auf Lager
100mg
484,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

(±)-2-propyl-4-Pentenoic acid (4-ene VPA) is a major metabolite of valproic acid.[1]  It undergoes β-oxidation to form reactive metabolites that induce hepatotoxicity in rats. 4-ene VPA is also neuroteratogenic, reducing forebrain size and inducing deformation of the neural tube in mouse embryos.[2]

Reference:
[1]. Tang, W., and Abbott, F.S. A comparative investigation of 2-propyl-4-pentenoic acid (4-ene VPA) and its α-fluorinated analogue: Phase II metabolism and pharmacokinetics. Drug Metab. Dispos. 25(2), 219-227 (1997).
[2]. Gofflot, F., Nassogne, M.C., Etzion, T., et al. In vitro neuroteratogenicity of valproic acid and 4-en-VPA. Neurotoxicol. Teratol. 17(4), 425-435 (1995).

Bewertungen

Review for (±)-2-propyl-4-Pentenoic Acid

Average Rating: 5 ★★★★★ (Based on Reviews and 28 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for (±)-2-propyl-4-Pentenoic Acid

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.